CD276 and glioblastoma: Among the immune stimulators, the expression level of CD276, CD40, CD80, CXCR4, ENTPD1, MICB, PDCD1LG2, TNFRSF14, and TNFSF13B was significantly increased in GBM samples compared to nontumor samples (Figure 6A).